IL-39 promotes chronic graft-versus-host disease by increasing T and B Cell pathogenicity.

Exp Hematol Oncol · 2022 · PMC9161463 · PMID 35655245

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

Furthermore, IL-39 levels showed an increasing trend in patients with M/S cGVHD compared to those with mild cGVHD (Fig. 5 A).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.